| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000001945 |
| Receipt No. | R000002367 |
| Official scientific title of the study | Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumor |
| Date of disclosure of the study information | 2009/06/01 |
| Last modified on | 2016/05/09 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumor | |
| Title of the study (Brief title) | Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumor | |
| Region |
|
|
| Condition | |||
| Condition | brain tumor | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate clinical effectiveness of Donepezil Hydrochloride to radiation-induced memory disturbance in patients with brain tumor |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Improvement of memory disturbance |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Donepezil Hydrochloride | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. no history of radiation therapy to brain
2. expect more than 6 months survival 3. patiets with small cell lung cancer who will receive prophylactic cranial irradiation 4.patiets with multiple brain tumors, without midline shift, nor without huge tumors of more than 5cm diameter 5.patients without disease of contra-indication to Donepezil Hydrochloride |
|||
| Key exclusion criteria | Patients of contra-indication to Donepezil Hydrochloride | |||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Ryohei Sasaki |
| Organization | Kobe University Hospital |
| Division name | Division of Radiation Oncology |
| Address | 7-5-2 Kusunokicho Chuouku Kobe city |
| TEL | 078-382-6104 |
| rsasaki@med.kobe-u.ac.jp | |
| Public contact | |
| Name of contact person | Yasuo Ejima |
| Organization | Kobe University Hospital |
| Division name | Division of Radiation Oncology |
| Address | 7-5-2 Kusunokicho Chuouku Kobe city |
| TEL | 078-382-6104 |
| Homepage URL | |
| ejimay@med.kobe-u.ac.jp | |
| Sponsor | |
| Institute | Department od Radiology, Kobe University Graduate School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department od Radiology, Kobe University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000002367 |